# Garnet Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/garnet-biotherapeutics

- Industry: Biotechnology
- Headquarters: Malvern, US
- Website: www.garnetbio.com
- Total disclosed funding: $13M
- Latest round: Series A (Jan 29, 2009)
- Investors on record: 4

## About

Garnet Biotherapeutics is a biotechnology company focused on advancing innovative therapies for challenging medical conditions. The company aims to transform treatment paradigms through its research and development initiatives.Founded in 1999, Garnet Biotherapeutics operates out of Malvern, US, specializing in biotherapeutic solutions. The company raised USD 10.4 mn in Series A financing in January 2009, led by SCP Vitalife Partners, with participation from Alliance Technology Ventures and Safeguard Scientifics. Garnet has completed a total of 2 deals since its inception.Garnet Biotherapeutics focuses on developing innovative therapies for various medical conditions, leveraging advanced biotherapeutic technologies. Its product offerings include proprietary therapeutics designed to address unmet clinical needs in specific disease areas, enhancing treatment options for patients.The company's revenue model is primarily driven by funding from investors, with a total amount raised of USD 10.4 mn to date, primarily from its Series A funding round. This financial backing supports its ongoing research and development efforts.Garnet Biotherapeutics plans to utilize its most recent funding of USD 10.4 mn to expand its research initiatives and develop new therapeutic products. The company is targeting to enter additional markets by 2025, focusing on North America and Europe to broaden its reach and impact in the biotherapeutic space.

## Funding rounds

- Series A, Jan 29, 2009, $10M — Safeguard Scientifics, SCP Vitalife Partners, Alliance Technology Ventures
- Series D, Feb 24, 2006, $2.7M — Novitas Capital, Safeguard Scientifics, Alliance Technology Ventures

## Investors

- Novitas Capital (https://capitalatlas.ai/funds/novitas-capital) — Series D
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series D, Series A
- Alliance Technology Ventures (https://capitalatlas.ai/funds/alliance-technology-ventures) — Series D, Series A
- SCP Vitalife Partners (https://capitalatlas.ai/funds/scp-vitalife-partners) — Series A